Stuart Bloor
- Virology top 0.2%
- HIV Research and Treatment 30
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 28
- HIV/AIDS Research and Interventions 18
- Epidemiology top 2%
- Autophagy in Disease and Therapy 5
- Physiology top 2%
- Immunology top 5%
- interferon and immune responses 5
-
- Vibrio bacteria research studies 5
-
- Hepatitis C virus research 5
-
- Biochemical and Molecular Research 4
- Co-authors
- Felix RandowBrendan LarderNatalia von MuhlinenTeresa L. M. ThurstonKurt HertogsGrigory RyzhakovSharon D. KempVeronica Miller
- Journals
- AIDS (10 papers)Antimicrobial Agents and Chemotherapy (4 papers)The Journal of Infectious Diseases (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stuart Bloor
49 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Virology 2.3k
- Infectious Diseases 2.3k
- Epidemiology 1.3k
- Physiology 174
- Immunology 653
Countries citing papers authored by Stuart Bloor
This map shows the geographic impact of Stuart Bloor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Bloor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Bloor more than expected).
Fields of papers citing papers by Stuart Bloor
This network shows the impact of papers produced by Stuart Bloor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Bloor. The network helps show where Stuart Bloor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stuart Bloor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 91 | |
| 5 | 2021 | 60 | |
| 6 | 2018 | 62 | |
| 7 | 2016 | 96 | |
| 8 | 2013 | 19 | |
| 9 | 2012 | 260 | |
| 10 | 2010 | 37 | |
| 11 | The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteriabreakdown → | 2009 | 694 |
| 12 | Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activationbreakdown → | 2009 | 595 |
| 13 | 2002 | 44 | |
| 14 | 2000 | 112 | |
| 15 | 2000 | 79 | |
| 16 | 2000 | 165 | |
| 17 | 2000 | 157 | |
| 18 | 1999 | 5 | |
| 19 | 1999 | 101 | |
| 20 | 1998 | 74 |
About Stuart Bloor
Stuart Bloor is a scholar working on Virology, Infectious Diseases and Endocrinology, having authored 49 papers that have together received 4.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (30 papers), HIV/AIDS drug development and treatment (28 papers), HIV/AIDS Research and Interventions (18 papers), interferon and immune responses (5 papers), Vibrio bacteria research studies (5 papers), Autophagy in Disease and Therapy (5 papers), Hepatitis C virus research (5 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Virology (2.3k citations), Infectious Diseases (2.3k citations) and Epidemiology (1.3k citations). Stuart Bloor has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Felix Randow, Brendan Larder, Natalia von Muhlinen, Teresa L. M. Thurston, Kurt Hertogs, Grigory Ryzhakov, Sharon D. Kemp, Veronica Miller, David Komander and P. Richard Harrigan. Their work appears in journals such as AIDS, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Journal of Virology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.